The Digital Source For China's Tech Innovation Since 2000

Search
Close

Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board Markets

December 19, 2021
Source: livermore.com livermore.com
News Snapshot:
BeiGene, a Beijing oncology company, began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong, and Shanghai.
Go To Original Source →
Tags: Beijing | Hong Kong | ipo | KONG | Shanghai

Other Related News:

China is now Russia's 'big brother': What Xi Jinping gained from Moscow visit

March 25, 2023

From Biden's gaffe to the 2 Michaels, China's presence was felt during president's visit

March 25, 2023

Two Michaels attend Biden speech, receive ovation

March 25, 2023

Talk of TikTok sale or ban complicates China-U.S. relations

March 24, 2023

Utah enacts age limits, curfews for social media use in major crackdown

March 24, 2023

TikTok CEO Shou Zi Chew's testimony will increase ban calls

March 24, 2023

Will TikTok be banned? Some Dems say ‘not so fast.’

March 24, 2023

Huawei touts camera on latest premium smartphone without 5G

March 24, 2023

Hong Kong makes new rules for specialist tech firm listings, cuts rev threshold

March 24, 2023
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2023 ChinaTechNews.com. A Service of Asia Media Network.
Twitter